TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Petrick, J. L. AU - McGlynn, K. A. PY - 2019 DA - 2019// TI - The changing epidemiology of primary liver cancer JO - Curr Epidemiol Rep VL - 6 UR - https://doi.org/10.1007/s40471-019-00188-3 DO - 10.1007/s40471-019-00188-3 ID - Petrick2019 ER - TY - JOUR AU - Plummer, M. AU - Martel, C. AU - Vignat, J. AU - Ferlay, J. AU - Bray, F. AU - Franceschi, S. PY - 2016 DA - 2016// TI - Global burden of cancers attributable to infections in 2012: a synthetic analysis JO - Lancet Glob Health VL - 4 UR - https://doi.org/10.1016/S2214-109X(16)30143-7 DO - 10.1016/S2214-109X(16)30143-7 ID - Plummer2016 ER - TY - JOUR AU - Perz, J. F. AU - Armstrong, G. L. AU - Farrington, L. A. AU - Hutin, Y. J. AU - Bell, B. P. PY - 2006 DA - 2006// TI - The contributions of hepatitis b virus and hepatitis c virus infections to cirrhosis and primary liver cancer worldwide JO - J Hepatology VL - 45 UR - https://doi.org/10.1016/j.jhep.2006.05.013 DO - 10.1016/j.jhep.2006.05.013 ID - Perz2006 ER - TY - JOUR AU - Schweitzer, A. AU - Horn, J. AU - Mikolajczyk, R. T. AU - Krause, G. AU - Ott, J. J. PY - 2015 DA - 2015// TI - Estimations of worldwide prevalence of chronic hepatitis b virus infection: A systematic review of data published between 1965 and 2013 JO - Lancet VL - 386 UR - https://doi.org/10.1016/S0140-6736(15)61412-X DO - 10.1016/S0140-6736(15)61412-X ID - Schweitzer2015 ER - TY - JOUR AU - Bruix, J. AU - Sherman, M. PY - 2011 DA - 2011// TI - Management of hepatocellular carcinoma: an update JO - Hepatology VL - 53 UR - https://doi.org/10.1002/hep.24199 DO - 10.1002/hep.24199 ID - Bruix2011 ER - TY - STD TI - Ghouri YA, Mian I and Rowe JH: Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinogen 16:1, 2017. PMID, DOI: https://doi.org/10.4103/jcar.JCar_9_16. ID - ref7 ER - TY - STD TI - Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R and Kelley S: Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 5(10): 835-844, 2006. PMID, DOI: https://doi.org/10.1038/nrd2130, 2006. ID - ref8 ER - TY - STD TI - Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D and Bruix J: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4): 378-390, 2008. PMID, DOI: https://doi.org/10.1056/NEJMoa0708857, 2008. ID - ref9 ER - TY - JOUR AU - Cheng, A. -. L. AU - Guan, Z. AU - Chen, Z. AU - Tsao, C. -. J. AU - Qin, S. AU - Kim, J. S. AU - Yang, T. -. S. AU - Tak, W. Y. AU - Pan, H. AU - Yu, S. AU - Xu, J. AU - Fang, F. AU - Zou, J. AU - Lentini, G. AU - Voliotis, D. AU - Kang, Y. -. K. PY - 2012 DA - 2012// TI - Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase iii sorafenib asia–pacific trial JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2011.12.006 DO - 10.1016/j.ejca.2011.12.006 ID - Cheng2012 ER - TY - STD TI - Lian J, Zou Y, Huang L, Cheng H, Huang K, Zeng J and Chen L: Hepatitis b virus upregulates ciap2 expression via pi3k/akt/nf-κb signaling pathway in liver cancer. Oncology letters In press 2019. PMID, DOI: ID - ref11 ER - TY - STD TI - Hu K, Fu M, Guan X, Zhang D, Deng X, Xiao Y, Chen R, Liu H and Hu Q: Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses. Vaccine 36(29): 4287-4297, 2018. PMID, DOI: https://doi.org/10.1016/j.vaccine.2018.05.118, 2018. ID - ref12 ER - TY - STD TI - Zhao R, Wang T-Z, Kong D, Zhang L, Meng H-X, Jiang Y, Wu Y-Q, Yu Z-X and Jin X-M: Hepatoma cell line hepg2.2.15 demonstrates distinct biological features compared with parental hepg2. World J Gastroenterol 17(9): 1152-1159, 2011. PMID, DOI: https://doi.org/10.3748/wjg.v17.i9.1152, 2011. ID - ref13 ER - TY - STD TI - Chan DW and Ng IO: Knock-down of hepatitis b virus x protein reduces the tumorigenicity of hepatocellular carcinoma cells. J Pathol 208(3): 372-380, 2006. PMID, DOI: https://doi.org/10.1002/path.1901, 2006. ID - ref14 ER - TY - STD TI - Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, De Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90. ID - ref15 ER - TY - JOUR AU - Chen, K. -. F. AU - Chen, H. -. L. AU - Tai, W. -. T. AU - Feng, W. -. C. AU - Hsu, C. -. H. AU - Chen, P. -. J. AU - Cheng, A. -. L. PY - 2011 DA - 2011// TI - Activation of phosphatidylinositol 3-kinase/akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells JO - J Pharmacol Exp Ther VL - 337 UR - https://doi.org/10.1124/jpet.110.175786 DO - 10.1124/jpet.110.175786 ID - Chen2011 ER - TY - STD TI - Casadei Gardini A, Frassineti GL, Foschi FG, Ercolani G and Ulivi P: Sorafenib and regorafenib in hbv- or hcv-positive hepatocellular carcinoma patients: analysis of resorce and sharp trials. Digest Liver Dis 49(8): 943-944, 2017. PMID, DOI: https://doi.org/10.1016/j.dld.2017.04.022, 2017. ID - ref17 ER - TY - STD TI - van Malenstein H, Dekervel J, Verslype C, Van Cutsem E, Windmolders P, Nevens F and van Pelt J: Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth. Cancer Lett 329(1): 74-83, 2013. PMID, DOI: https://doi.org/10.1016/j.canlet.2012.10.021, 2013. ID - ref18 ER - TY - STD TI - Heqing Y, Bin L, Xuemei Y and Linfa L: The role and mechanism of autophagy in sorafenib targeted cancer therapy. Crit Rev Oncol Hematol 100: 137-140, 2016. PMID, DOI: https://doi.org/10.1016/j.critrevonc.2016.02.006, 2016. ID - ref19 ER - TY - STD TI - Zhu YJ, Zheng B, Wang HY and Chen L: New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacol Sin 38(5): 614-622, 2017. PMID: PMC5457690, DOI: https://doi.org/10.1038/aps.2017.5, 38, 5, 614, 622. ID - ref20 ER - TY - JOUR AU - Witt-Kehati, D. AU - Fridkin, A. AU - Alaluf, M. B. AU - Zemel, R. AU - Shlomai, A. PY - 2018 DA - 2018// TI - Inhibition of pmapk14 overcomes resistance to sorafenib in hepatoma cells with hepatitis b virus JO - Transl Oncol VL - 11 UR - https://doi.org/10.1016/j.tranon.2018.02.015 DO - 10.1016/j.tranon.2018.02.015 ID - Witt-Kehati2018 ER - TY - STD TI - Roscioli E, Hamon R, Ruffin RE, Grant J, Hodge S, Zalewski P and Lester S: Birc3 single nucleotide polymorphism associate with asthma susceptibility and the abundance of eosinophils and neutrophils. J Asthma 54(2): 116-124, 2017. PMID, DOI: https://doi.org/10.1080/02770903.2016.1196371, 2017. ID - ref22 ER - TY - STD TI - Jiang X, Li C, Lin B, Hong H, Jiang L, Zhu S, Wang X, Tang N, Li X, She F and Chen Y: Ciap2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the nf-kappab pathway. Cancer Sci 108(6): 1144-1156, 2017. PMID: PMC5480088, DOI: https://doi.org/10.1111/cas.13236, 108, 6, 1144, 1156. ID - ref23 ER - TY - STD TI - Wang D, Berglund AE, Kenchappa RS, MacAulay RJ, Mule JJ and Etame AB: Birc3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats. Sci Rep 7(1): 9350, 2017. PMID: PMC5570925, DOI: https://doi.org/10.1038/s41598-017-09503-8, 7, 1, 9350. ID - ref24 ER - TY - STD TI - Wu HH, Wu JY, Cheng YW, Chen CY, Lee MC, Goan YG and Lee H: Ciap2 upregulated by e6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/akt pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer. Clin Cancer Res 16(21): 5200-5210, 2010. PMID, DOI: https://doi.org/10.1158/1078-0432.Ccr-10-0020, 2010. ID - ref25 ER - TY - STD TI - Gill C, Dowling C, O'Neill AJ and Watson RW: Effects of ciap-1, ciap-2 and xiap triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation. Mol Cancer 8: 39, 2009. PMID: PMC2706796, DOI: https://doi.org/10.1186/1476-4598-8-39, 8, 1, 39. ID - ref26 ER - TY - STD TI - Wang Q, Wang X and Evers BM: Induction of ciap-2 in human colon cancer cells through pkc delta/nf-kappa b. J Biol Chem 278(51): 51091-51099, 2003. PMID, DOI: https://doi.org/10.1074/jbc.M306541200, 2003. ID - ref27 ER - TY - STD TI - Wang HC, Huang W, Lai MD and Su IJ: Hepatitis b virus pre-s mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97(8): 683-688, 2006. PMID, DOI: https://doi.org/10.1111/j.1349-7006.2006.00235.x, 2006. ID - ref28 ER - TY - STD TI - Menolfi D, Delamarre A, Lengronne A, Pasero P and Branzei D: Essential roles of the smc5/6 complex in replication through natural pausing sites and endogenous DNA damage tolerance. Mol Cell 60(6): 835-846, 2015. PMID: PMC4691243, DOI: https://doi.org/10.1016/j.molcel.2015.10.023, 60, 6, 835, 846. ID - ref29 ER - TY - STD TI - Tropberger P, Mercier A, Robinson M, Zhong W, Ganem DE and Holdorf M: Mapping of histone modifications in episomal hbv cccdna uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci U S A 112(42): E5715-E5724, 2015. PMID: PMC4620859, DOI: https://doi.org/10.1073/pnas.1518090112, 112, 42, E5715, E5724. ID - ref30 ER - TY - STD TI - Ringelhan M, O'Connor T, Protzer U and Heikenwalder M: The direct and indirect roles of hbv in liver cancer: prospective markers for hcc screening and potential therapeutic targets. J Pathol 235(2): 355-367, 2015. PMID, DOI: https://doi.org/10.1002/path.4434, 2015. ID - ref31 ER - TY - STD TI - Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, Tong JH, Lai PB, Chan HL, To KF, Chan TF and Wong N: Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 25(3): 335-349, 2014. PMID, DOI: https://doi.org/10.1016/j.ccr.2014.01.030, 2014. ID - ref32 ER - TY - STD TI - Chao CC: Inhibition of apoptosis by oncogenic hepatitis b virus x protein: Implications for the treatment of hepatocellular carcinoma. World J Hepatol 8(25): 1061-1066, 2016. PMID: PMC5026997, DOI: https://doi.org/10.4254/wjh.v8.i25.1061, 8, 25, 1061, 1066. ID - ref33 ER - TY - JOUR AU - Chang, C. S. AU - Huang, S. M. AU - Lin, H. H. AU - Wu, C. C. AU - Wang, C. J. PY - 2007 DA - 2007// TI - Different expression of apoptotic proteins between hbv-infected and non-hbv-infected hepatocellular carcinoma JO - Hepatogastroenterology VL - 54 ID - Chang2007 ER -